Burden of Influenza and Respiratory Syncytial Viruses in Suspected COVID-19 Patients: A Cross-Sectional and Meta-Analysis Study
Viruses · 2023
DOI: 10.3390/v15030665 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Viruses, 2023. Verfasst von Vivaldo Gomes da Costa und 16 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Estudos Genômicos, Departamento de Biologia, Instituto de Biociências Letras e Ciências Exatas, Universidade Estadual Paulista Júlio d…. Hauptthemen laut MEDLINE: Coinfection, COVID-19, Influenza, Human, Respiratory Syncytial Virus Infections. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, RedeVírus/MCTI, FAPESP.
Abstract (Originalsprache)
Non-SARS-CoV-2 respiratory viral infections, such as influenza virus (FluV) and human respiratory syncytial virus (RSV), have contributed considerably to the burden of infectious diseases in the non-COVID-19 era. While the rates of co-infection in SARS-CoV-2-positive group (SCPG) patients have been determined, the burden of other respiratory viruses in the SARS-CoV-2-negative group (SCNG) remains unclear. Here, we conducted a cross-sectional study (São José do Rio Preto county, Brazil), and we collected our data using a meta-analysis to evaluate the pooled prevalence of FluV and RSV among SCNG patients. Out of the 901 patients suspected of COVID-19, our molecular results showed positivity of FluV and RSV in the SCNG was 2% (15/733) and 0.27% (2/733), respectively. Co-infection with SARS-CoV-2 and FluV, or RSV, was identified in 1.7% of the patients (3/168). Following our meta-analysis, 28 studies were selected (n = 114,318 suspected COVID-19 patients), with a pooled prevalence of 4% (95% CI: 3–6) for FluV and 2% (95% CI: 1–3) for RSV among SCNG patients were observed. Interestingly, FluV positivity in the SCNG was four times higher (OR = 4, 95% CI: 3.6–5.4, p < 0.01) than in the SCPG. Similarly, RSV positivity was significantly associated with SCNG patients (OR = 2.9, 95% CI: 2–4, p < 0.01). For subgroup analysis, cold-like symptoms, including fever, cough, sore throat, headache, myalgia, diarrhea, and nausea/vomiting, were positively associated (p < 0.05) with the SCPG. In conclusion, these results show that the pooled prevalence of FluV and RSV were significantly higher in the SCNG than in the SCPG during the early phase of the COVID-19 pandemic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratório de Estudos Genômicos, Departamento de Biologia, Instituto de Biociências Letras e Ciências Exatas, Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP), São José do Rio Preto 15054-000, SP, Brazil.
- Laboratório de Pesquisas em Virologia (LPV), Departamento de Doenças Dermatológicas, Infecciosas e Parasitárias, Faculdade de Medicina de São José do Rio Preto (FAMERP), São José do Rio Preto 15090-000, SP, Brazil.
- Laboratório de Virologia Molecular, Departamento de Ciências Biológicas, Faculdade de Ciências Farmacêuticas (UNESP), Araraquara 14800-903, SP, Brazil.
- Departamento de Análises Clínicas, Faculdade de Ciências Farmacêuticas (UNESP), Araraquara 14801-360, SP, Brazil.
- Instituto de Biotecnologia, Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP), Botucatu 18607-440, SP, Brazil.
- Laboratório de Microbiologia Molecular, Instituto de Ciências da Saúde, Universidade Feevale, Novo Hamburgo 93525-075, RS, Brazil.
ORCID-Profile: Vivaldo Gomes da Costa, Ana Júlia Chaves Gomes, Cíntia Bittar, Guilherme Rodrigues Fernandes Campos, Maurício Lacerda Nogueira, João Pessoa Araujo, Fernando Rosado Spilki
Förderung
- NIAID NIH HHS
- RedeVírus/MCTI
- FAPESP
- CREATE-NEO
- Unesp Post-doctoral Scholarship
- CNPq Post-doctoral Scholarship
Zitieren
APA
Costa, V. G. D., Gomes, A. J. C., Bittar, C., Geraldini, D. B., Previdelli da Conceição, P. J., Cabral, Á. S., Carvalho, T., Biselli, J. M., Provazzi, P. J. S., Campos, G. R. F., Sanches, P. R. D. S., Costa, P. I., Nogueira, M. L., Araujo, J. P., Spilki, F. R., Calmon, M. F., & Rahal, P. (2023). Burden of Influenza and Respiratory Syncytial Viruses in Suspected COVID-19 Patients: A Cross-Sectional and Meta-Analysis Study. Viruses. https://doi.org/10.3390/v15030665
Vancouver
Costa VGD, Gomes AJC, Bittar C, Geraldini DB, Previdelli da Conceição PJ, Cabral ÁS, et al. Burden of Influenza and Respiratory Syncytial Viruses in Suspected COVID-19 Patients: A Cross-Sectional and Meta-Analysis Study. Viruses. 2023. doi:10.3390/v15030665
BibTeX
@article{Costa2023,
author = {Costa, Vivaldo Gomes da and Gomes, Ana Júlia Chaves and Bittar, Cíntia and Geraldini, Dayla Bott and Previdelli da Conceição, Pâmela Jóyce and Cabral, Ágata Silva and Carvalho, Tamara and Biselli, Joice Matos and Provazzi, Paola Jocelan Scarin and Campos, Guilherme Rodrigues Fernandes and Sanches, Paulo Ricardo da Silva and Costa, Paulo Inácio and Nogueira, Maurício Lacerda and Araujo, João Pessoa and Spilki, Fernando Rosado and Calmon, Marília Freitas and Rahal, Paula},
title = {Burden of Influenza and Respiratory Syncytial Viruses in Suspected COVID-19 Patients: A Cross-Sectional and Meta-Analysis Study},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15030665}
}
EUVIMED